Virtual Events for Interventional Oncology
All (-)
-
ECIO 2023 - Present and future of cryoablation: where are we heading?
Apr 18, 2023
External Link( 82.0 KB )
A leading panel of experts at #ECIO2023 assisted us in deep diving into cryoablation therapy to discover more about its latest evidence and application and application in MSK, RCC and Breast tumors through our sessions.
Moderator: Prof. Laura Crocetti -
EANM 2022 - Y-90 Glass Microspheres, Personalised Dosimetry, Gudelines and Clinical Data
Oct 16, 2022
External Link( 92.0 KB )
A panel of international experts share the latest TARE clinical evidence through cases and discussions and review how this translate into the guidelines for both primary and secondary liver cancer.
Moderator: Prof. Ken Herrmann -
ECIO 2022 – SIRT’s position in HCC Guidelines and beyond
May 09, 2022
External Link( 12.0 KB )
#ECIO2022 has been an amazing first hybrid experience. Meeting our customers face-to-face and sharing the latest updates has been a pleasure! If you missed us, the symposium recording is available here!
Chair: Prof. Riad Salem -
EASL Liver Cancer Summit 2022 - Radioembolisation in the BCLC and beyond: An MDT approach
Feb 18, 2022
External Link( 2.0 MB )
EASL Digital Liver Cancer Summit 2022 - an international congress dedicated to the latest data and findings in the fight against primary liver cancer. Watch our virtual symposium on Radioembolisation and the latest data from the official update of the Barcelona Clinic Liver Cancer (BCLC).
-
The results of the Target Study with Prof. Riad Salem and Prof. Marnix Lam
Feb 17, 2022
External Link( 18.0 KB )
Target Study confirms the significance of tumour absorbed dose to tumour response and overall survival
-
The Cost-Effectiveness of TheraSphere in Patients with Hepatocellular Carcinoma
Feb 16, 2022
External Link( 16.0 KB )
Stuart Mealing at ECIO 2021 shows the Cost-Effectiveness of SIRT in early and intermediate staged HCC patients
-
EPOCH: The phase III RCT with Y-90 TheraSphere™
Feb 15, 2022
External Link( 66.0 KB )
Evaluating 2nd line treatment with Y-90 TheraSphere in patients with colorectal liver metastases. CIRSE 2021 Congress, Boston Scientific symposium, September 26th 2021
-
Discover your options and radial access horizons with TRUSELECT™
Feb 10, 2021
External Link( 41.0 KB )
Prof. Mark W. Little describes the technical aspects of Transradial Access in peripheral interventions utilizing TRUSELECT 2.0F microcatheter and recommend a framework for transition to a radial strategy.
-
The power of visibility with DC Bead LUMI™ – Case based discussion
Dec 08, 2020
External Link( 529.0 KB )
Through a case based discussion Dr. Tobias Jakobs explains when, why and how he uses DC Beads LUMI in HCC patients.
-
TRUSELECTivity in Small Vessel and Prostate Artery Embolisation. Why TRUSELECT™
Nov 25, 2020
External Link( 424.0 KB )
Prof. Florian Wolf shares cases with the newly launched TRUSELECT 2F microcatheter and explains when and why to use it in small vessels, tortuous or distal anatomies.
-
A Forum for Pharmacists - Build your knowledge of how loading instructions are developed and regulated and their interpretation in the real world.
Nov 10, 2020
External Link( 73.0 KB )
Watch our DC Bead innovation team, Pedro Garcia and Venisha Patel, expertly guide you through DC Bead™ drug loading process and their experience in pharmacy. Understand the development and advancements of DC Bead™ and DC Bead LUMI™ and gain knowledge and understanding of IFU loading instructions and regulations.
-
Optimizing SIRT Planning for Superior Patient Outcomes
Oct 30, 2020
External Link( 28.0 MB )
EANM congress, Boston Scientific symposium October 30th 2020
-
DEB-TACE Management and TACE in Combination Therapy - Dr Roman Kloeckner
Oct 15, 2020
External Link( 343.0 KB )
Third of three podcasts on DEB-TACE with DC Bead Dr Roman Kloeckner will discuss 1) cTACE vs DEB-TACE, at minute 00:37 2) When to switch to systemic therapy, at minute 01:36 3) Combination therapy, at minute 03:03 - TACE + Ablation - TACE + TKI - TACE + Immunotherapy
-
DEB-TACE with DC Bead - Clinical considerations - Dr Roman Kloeckner
Oct 15, 2020
External Link( 244.0 KB )
Second of three podcasts on DEB-TACE with DC Bead Dr Roman Kloeckner will discuss 1) Indications for TACE - stage migration, at minute 0:27 2) Pre-, intra- and postinterventional imaging, at minute 1:42 3) Cases TACE vs SIRT, at minute 5:55
-
DEB-TACE with DC Bead - Technical considerations - Dr Roman Kloeckner
Oct 15, 2020
External Link( 213.0 KB )
First of three podcasts on DEB-TACE with DC Bead Dr Roman Kloeckner will discuss 1) Catheters and Access Approaches, at minute 0:30 2) Bead Sizes, at minute 5:29 3) Application Technique and Mixing, at minute 07:55 4) Selectivity and Endpoint, at minute 09:35
-
Beads innovations in clinical usage: DC Bead™ to DC Bead LUMI™
Oct 13, 2020
External Link( 8.0 MB )
Pedro Garcia provides insight on the innovation and development to create DC Bead LUMI. Dr Pete Littler shares his clinical experience where using DC Bead LUMI makes a difference.
-
Combination of SIRT with Systemic Therapy in HCC
Oct 09, 2020
External Link( 13.0 MB )
Prof. Jens Ricke shares the existing data about combination of SIRT with Systemic Therapy in HCC
-
Immunotherapy – What we see until now? What do we expect in future?
Oct 09, 2020
External Link( 14.0 MB )
Prof. Heiner Wedemeyer presents existing data on immunotherapy for the treatment of HCC and future expectations
-
What can SIRT offer for ICC?
Oct 09, 2020
External Link( 29.0 MB )
Dr Julien Edeline speaks about what can SIRT offer for intrahepatic cholangiocarcinoma patients.
-
Where we are with SIRT in mCRC? What do we expect in future?
Oct 09, 2020
External Link( 37.0 MB )
Dr Pilar Garcia Alfonso reviews the current clinical evidence for SIRT in mCRC and describes the EPOCH trial
-
Continuation of care for oncology patients during pandemic
Oct 08, 2020
External Link( 40.0 MB )
Prof. Ken Herrmann covers the organizational considerations, logistical challenges and medical implications to ensure continuation of care for oncology patients during pandemic
-
Dosimetry guidelines for TheraSphere in HCC
Oct 08, 2020
External Link( 29.0 MB )
Prof. Marnix Lam shares the recommendations of an international multidisciplinary working group about the clinical and dosimetric considerations for TheraSphere in HCC treatment
-
Dosimetry-guided treatment planning in Nuclear Medicine
Oct 08, 2020
External Link( 96.0 KB )
Prof. Mark Konijnenberg shares how dosimetry-guided treatment should provide the right balance between harm and benefit; eg low toxicity and increased survival.
-
Personalised dosimetry in real life: the PROACTIF experience
Oct 08, 2020
External Link( 10.0 MB )
Prof. Thierry de Baere introduces the PROACTIF experience and focuses on personalised dosimetry
-
Personalised dosimetry: from concept to reality with DOSISPHERE-01 trial
Oct 08, 2020
External Link( 23.0 MB )
Prof. Etienne Garin discusses personalised dosimetery from concept to reality with DOSISPHERE-01 trial
-
How SIRT can fill the gaps? Can SIRT lead to curative treatment in HCC?
Oct 07, 2020
External Link( 23.0 MB )
Dr Droz Dit Busset discussed the place of SIRT in the current HCC treatment algorithm and whether it can lead to cure.
-
Personalized Dosimetry – an option or a must?
Oct 07, 2020
External Link( 10.0 MB )
Dr Lambros Tselikas speaks about personalized dosimetry in SIRT and explains why it is a must.
-
SIRT during Pandemic
Oct 07, 2020
External Link( 34.0 MB )
Prof. Irene Bargellini discusses what SIRT could offer during the Covid-19 pandemic
-
Where we are with the existing guidelines for the treatment of HCC
Oct 07, 2020
External Link( 18.0 MB )
Dr Maria Varela reviews the existing guidelines, identifies the gaps and the possible role of SIRT in the HCC treatment
-
Cryoablation of renal tumors: Treating more patients per day – Is conscious sedation the solution?
Sep 29, 2020
External Link( 5.0 MB )
Prof. Ole Graumann provides tips and tricks for treating the right RCC patients with conscious sedation including needle placement and post treatment recovery.
-
DEB-TACE with DC Bead™ vs cTACE from a clinical and health economic perspective
Sep 14, 2020
External Link( 80.0 KB )
Prof. Irene Bargellini shares why DC Beads™ is a cost-effective intervention vs cTACE in HCC and the patient benefits and QALY when treated with DEB-TACE.
-
Optimizing SIRT planning for superior patient outcomes
Sep 13, 2020
External Link( 12.0 KB )
Prof. Eric Vibert introduces the symposium
-
Optimizing SIRT planning for superior patient outcomes
Sep 13, 2020
External Link( 12.0 KB )
Personalised dosimetry: unique to glass microspheres. Dr Yan Rolland
-
Optimizing SIRT planning for superior patient outcomes
Sep 13, 2020
External Link( 16.0 KB )
Case examples of personalised dosimetry in curative and palliative scenarios. Dr Rafael Duran.
-
Optimizing SIRT planning for superior patient outcomes. Discussion and Q&A
Sep 13, 2020
External Link( 15.0 KB )
Panelists discussion
-
Optimizing SIRT planning for superior patient outcomes. Refine your SIRT Planning
Sep 13, 2020
External Link( 16.0 KB )
Prof. Marnix Lam
-
Y90 A Step Towards Curative Therapies for HCC (ILCA symposium)
Sep 13, 2020
External Link( 52.0 MB )
00:00 Talia Baker shares long term outcomes of liver transplant 11:16 Pete Littler shares cases with SIRT for downstaging 22:03 Julien Edeline provides his view on positioning SIRT in the treatment algorithm
-
Renal Cryoablation – Conscious sedation and optimization of patient workflow
Sep 12, 2020
External Link( 16.0 KB )
Prof. Ole Graumann introduces different conscious sedation methods and explains how it can optimize patient workflow in a cost effective way.
-
Advancing the Science in Lung Cryoablation
Aug 25, 2020
External Link( 26.0 MB )
Dr Matthew Callstrom speaks about the results from the SOLSTICE study which evaluate the safety and efficacy of cryoablation to treat pulmonary metastatic disease.
-
Lead the way: Personalise your SIRT dosimetry with TheraSphere™ and Simplicit90Y™
Jul 30, 2020
External Link( 20.0 KB )
Prof. Boris Guiu and Prof. Etienne Garin speak on the unique clinical evidence demonstrating superiority of TheraSphere personalised dosimetry for HCC patients. They explain how Simplicit90Y enables rapid and effective implementation of TheraSphere personalised dosimetry in clinical practice.
-
Ice to success. Renal Cryoablation from an Expert´s Perspective
Jul 09, 2020
External Link( 17.0 KB )
Learn from two experts, coming from different perspectives: Interventional Radiology and Urology. Dr David Breen and Dr Brnolf Lagerveld discusses technique & optimization, patient selection and limitations, tips & tricks, RCC evidence and how to drive collaboration.
-
New Approach in Endoleak Type II Management
Jul 03, 2020
External Link( 22.0 KB )
Prof. Gargiulo, Prof. Froio and Dr Mascoli discuss the predictive factors in indentifying high-risk patients as well as outcomes of routine sac embolisation in the patient population.
-
EPOCH: The phase III RCT with Y-90 TheraSphere™, ESMO Symposium
External Link( 555.0 KB )
Evaluating 2nd line treatment with Y-90 TheraSphere in patients with colorectal liver metastases. ESMO 2021 Congress, Boston Scientific symposium, September 21st 2021
-
Evidence and clinical appication of SIRT in early and intermediate HCC
External Link( 25.0 KB )
Dr. Irene Bargellini at ECIO 2021 provides evidence on the versatility of SIRT in early HCC disease and on the treatment of heterogeneous intermediate HCC patients with Y90
-
SIRT: The versatility of current HCC treatment & opportunities for the future
External Link( 62.0 KB )
EASL 2021 - Digital Liver Cancer Summit Chair: Prof. Maren Schulze
Physician Education
